Active substance
Tetrahydrozoline
- SFDA 1
- US FDA 2
- Health Canada 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| VISINE EYE DROPS 0.05% | 0.05 % | Eye drops · Ocular use | 1 Dropper Container | SAR 6.15 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ORIGINAL EYE DROPS | 02273446 | 0.05 % / W/V | SOLUTION · OPHTHALMIC | JUNO OTC INC |
| VISINE ORIGINAL | 01942425 | 0.05 % | DROPS · OPHTHALMIC | JOHNSON & JOHNSON INC |
Combinations containing Tetrahydrozoline
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.